fbpx
Connect with us

News

Elsevier acquires healthcare simulation developer

Avatar photo

Published

on

Elsevier acquired to boost its portfolio of digital health services

Global research publishing and information analytics company Elsevier has acquired a Florida-based developer of virtual simulations in nursing and healthcare education.

Shadow Health’s digital clinical experiences train and prepare nurses and healthcare practitioners for clinical settings. Its simulations, powered by Shadow Health’s Conversation Engine, enable learners to practice and apply their clinical reasoning skills through life-like interactions with a range of virtual patients.

Shadow Health products are currently used in more than 900 institutions across North America.

David Massias, co-founder and CEO of Shadow Health, said: “The global pandemic has brought the need for virtual simulations in nursing and healthcare education into sharp focus.

“What is clear is that when we invest in better training for nurses, we’ll see better outcomes for patients. Shadow Health’s digital clinical experiences allow learners to develop their clinical judgment and communication skills by interviewing, examining, and treating virtual patients.

“I’m very proud of everyone at Shadow Health. They have a heart for healthcare, for patients and their families – and work tirelessly to serve our customers better. Now, together with Elsevier, we are excited to work as one team to accelerate global health, one patient and one nurse at a time.”

The acquisition is designed to enhance Elsevier’s portfolio of digital health services.

Jan Herzhoff, president of global health markets at Elsevier, said: “Clinical settings are often high-pressure environments. At Elsevier, we are proud to be a trusted partner for nurses around the world throughout their career from education to practice.

“The safe, engaging learning environment Shadow Health provides will further support nurses and healthcare professionals in their important work to improve patient outcomes.”

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending stories